← Leaderboards
Jessica Lynette Montoya
University Of California, San Diego
$1,028,700
Attributed
$1,028,700
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $205.7K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,028,700 · 1
By mechanism
K23$1,028,700 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Scott L Letendre$25,948,231
- Angela Robertson Bazzi$5,083,310
- Shelley May Warlow$971,173
- David J Moore$20,232,553
- Jennifer E Iudicello$8,105,776
Others in their field
Other Emerging Leaders on “Abstinence”
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Gonul Velicelebi · Sanford Burnham Prebys Medical Discovery Institute$8,970,452
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- Susan Zief · Mathematica Inc.$8,271,888
- Miriam Komaromy · Rand Corporation$6,556,702
- Jamie Elizabeth Newman · Research Triangle Institute$5,937,082
Research focus
AbstinenceEvidence BaseAddictionAntiretroviral TherapyAreaAdherenceBehavior TherapyBiologicalCareerCareer DevelopmentCaringClinical TrialsCombatComorbidityContingency ManagementContinuity Of Patient CareDesignDevelopment PlansEffective InterventionEffectivenessEffectiveness EvaluationEpidemicEvaluationEvidence Based Practice
Grant awards (5)
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine$205,740
K23 · FY2025 · DA · contact PI
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine$205,740
K23 · FY2024 · DA · contact PI
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine$205,740
K23 · FY2023 · DA · contact PI
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine$205,740
K23 · FY2022 · DA · contact PI
An integrated incentive-based treatment to optimize HIV treatment engagement among persons who use methamphetamine$205,740
K23 · FY2021 · DA · contact PI